AIMC Journal:
Drugs & aging

Older adults represent most patients with cancer worldwide, yet they remain substantially underrepresented in randomized clinical trials (RCTs), limiting the evidence available to guide treatment decisions in this growing population. Real-world data ...

Artificial intelligence (AI) is revolutionizing clinical trials in geriatric populations by addressing the unique challenges of aging-related diseases and patient heterogeneity. Advanced AI techniques, including machine learning, deep learning, and A...